Reviva Pharmaceuticals Warrants
RVPHW
RVPHW was delisted on the 12th of December, 2025.
3 hedge funds and large institutions have $493 invested in Reviva Pharmaceuticals Warrants in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
0.02% less ownership
Funds ownership: 0.05% → 0.03% (-0.02%)
51% less capital invested
Capital invested by funds: $1K → $493 (-$507)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$828 |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$5 |
| 3 |
CS
Clear Street
New York
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $489 | +$828 | +15,201 | New |
|
|
2
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $3 | +$5 | +100 | New |
|
|
CS
3
Clear Street
New York
| $1 | +$1 | +22 | New |
|
|
VF
4
Virtu Financial
New York
| – | -$1K | -16,100 | Closed |
|
RVPHW Hedge Fund Activity: Q2 2025 in Review
3 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q2 2025, worth a combined $493 — down 51% from $1K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RVPHW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $828. The largest seller was Virtu Financial, exiting entirely with an estimated $1K sold.
- 3 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q2 2025, up from 1 in Q1 2025.
- Funds reported $493 of Reviva Pharmaceuticals Warrants stock for Q2 2025, down 51% quarter-over-quarter.
- 3 funds opened new Reviva Pharmaceuticals Warrants positions in Q2 2025 and 1 closed out, a net change of +2 holders.
- The largest Reviva Pharmaceuticals Warrants buyer in Q2 2025 was Susquehanna International Group, an estimated $828 added.
- The largest Reviva Pharmaceuticals Warrants seller in Q2 2025 was Virtu Financial, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2025.